S.R. Schill & Associates’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,959
| Closed | -$468K | – | 86 |
|
|
2024
Q1 | $468K | Sell |
2,959
-396
| -12% | -$63K | 0.2% | 49 |
|
|
2023
Q4 | $526K | Sell |
3,355
-1
| -0% | -$153 | 0.23% | 42 |
|
|
2023
Q3 | $523K | Sell |
3,356
-108
| -3% | -$17.8K | 0.25% | 41 |
|
|
2023
Q2 | $573K | Sell |
3,464
-1,242
| -26% | -$200K | 0.26% | 37 |
|
|
2023
Q1 | $729K | Sell |
4,706
-995
| -17% | -$161K | 0.34% | 29 |
|
|
2022
Q4 | $1.01M | Buy |
5,701
+339
| +6% | +$58.5K | 0.5% | 27 |
|
|
2022
Q3 | $876K | Sell |
5,362
-1,192
| -18% | -$202K | 0.47% | 24 |
|
|
2022
Q2 | $1.16M | Buy |
6,554
+265
| +4% | +$47.2K | 0.58% | 23 |
|
|
2022
Q1 | $1.11M | Buy |
6,289
+197
| +3% | +$33.5K | 0.47% | 24 |
|
|
2021
Q4 | $1.04M | Sell |
6,092
-3,615
| -37% | -$592K | 0.42% | 26 |
|
|
2021
Q3 | $1.57M | Sell |
9,707
-840
| -8% | -$143K | 0.67% | 20 |
|
|
2021
Q2 | $1.74M | Buy |
10,547
+191
| +2% | +$31.6K | 0.69% | 21 |
|
|
2021
Q1 | $1.7M | Buy |
10,356
+296
| +3% | +$47.9K | 0.75% | 20 |
|
|
2020
Q4 | $1.58M | Sell |
10,060
-2,422
| -19% | -$357K | 0.73% | 19 |
|
|
2020
Q3 | $1.86M | Sell |
12,482
-521
| -4% | -$77.1K | 0.94% | 18 |
|
|
2020
Q2 | $1.83M | Sell |
13,003
-1,794
| -12% | -$261K | 1.07% | 20 |
|
|
2020
Q1 | $1.94M | Buy |
14,797
+3,050
| +26% | +$433K | 1.3% | 14 |
|
|
2019
Q4 | $1.71M | Buy |
11,747
+50
| +0.4% | +$6.78K | 0.93% | 24 |
|
|
2019
Q3 | $1.51M | Sell |
11,697
-1,957
| -14% | -$258K | 0.84% | 24 |
|
|
2019
Q2 | $1.9M | Buy |
13,654
+96
| +0.7% | +$13.3K | 1.18% | 18 |
|
|
2019
Q1 | $1.9M | Sell |
13,558
-515
| -4% | -$69K | 1.14% | 20 |
|
|
2018
Q4 | $1.82M | Buy |
14,073
+258
| +2% | +$36K | 1.28% | 18 |
|
|
2018
Q3 | $1.91M | Buy |
13,815
+2,885
| +26% | +$383K | 1.17% | 22 |
|
|
2018
Q2 | $1.33M | Buy |
10,930
+224
| +2% | +$27.9K | 0.81% | 27 |
|
|
2018
Q1 | $1.37M | Sell |
10,706
-42
| -0.4% | -$5.68K | 0.85% | 28 |
|
|
2017
Q4 | $1.5M | Buy |
10,748
+214
| +2% | +$29.8K | 0.93% | 25 |
|
|
2017
Q3 | $1.37M | Buy |
10,534
+40
| +0.4% | +$5.3K | 0.82% | 27 |
|
|
2017
Q2 | $1.39M | Buy |
10,494
+40
| +0.4% | +$5.1K | 0.87% | 23 |
|
|
2017
Q1 | $1.3M | Sell |
10,454
-166
| -2% | -$19.8K | 0.83% | 25 |
|
|
2016
Q4 | $1.22M | Buy |
10,620
+440
| +4% | +$50.8K | 0.8% | 23 |
|
|
2016
Q3 | $1.2M | Sell |
10,180
-1,336
| -12% | -$162K | 0.79% | 25 |
|
|
2016
Q2 | $1.4M | Sell |
11,516
-193
| -2% | -$21.9K | 0.94% | 21 |
|
|
2016
Q1 | $1.27M | Buy |
11,709
+599
| +5% | +$62K | 0.86% | 21 |
|
|
2015
Q4 | $1.14M | Buy |
11,110
+6,121
| +123% | +$616K | 0.79% | 27 |
|
|
2015
Q3 | $466K | Sell |
4,989
-11
| -0.2% | -$1.06K | 0.33% | 41 |
|
|
2015
Q2 | $487K | Buy |
5,000
+113
| +2% | +$11.3K | 0.33% | 43 |
|
|
2015
Q1 | $492K | Sell |
4,887
-86
| -2% | -$8.74K | 0.33% | 41 |
|
|
2014
Q4 | $520K | Buy |
+4,973
| New | +$524K | 0.48% | 32 |
|
Other funds holding JNJ
S.R. Schill & Associates's JNJ Position: Q2 2024 in Review
S.R. Schill & Associates sold out of Johnson & Johnson (JNJ) in Q2 2024, closing a stake of 2,959 shares — an estimated $468K sold.
S.R. Schill & Associates first reported a position in JNJ in Q4 2014 and held it in 38 quarters. The position peaked at $1.94M in Q1 2020. 3,802 funds tracked by Wall St. Rank hold JNJ as of Q2 2024.
- S.R. Schill & Associates reported no remaining Johnson & Johnson position as of Q2 2024 after selling out during the quarter.
- S.R. Schill & Associates sold 2,959 Johnson & Johnson shares in Q2 2024, an estimated $468K.
- S.R. Schill & Associates first reported a position in Johnson & Johnson in Q4 2014 and held it in 38 quarters.
- S.R. Schill & Associates's Johnson & Johnson position peaked at $1.94M in Q1 2020.
- 3,802 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2024.
Based on S.R. Schill & Associates's 13F filing for Q2 2024, filed 15 Jul 2024.